FAQ

PRO 2000

Known as: 2000 pro, PRO-2000, PRO2000 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1997-2015
012319972015

Related topics

Related topics

2 relations

Broader (2)

NaphthalenesulfonatesPolymers

Related mentions per year

Related mentions per year

1937-2018
19401960198020002020
PRO 2000
Polymers
Naphthalenesulfonates

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2014
2014
HPTN 035 phase II/IIb randomised safety and effectiveness study of the vaginal microbicides BufferGel and 0.5% PRO 2000 for the prevention of sexually transmitted infections in women.
OBJECTIVES To estimate the effectiveness of candidate microbicides BufferGel and 0.5% PRO 2000 Gel (P) (PRO 2000) for prevention… (More)
Is this relevant?
2013
2013
Long-term consistent use of a vaginal microbicide gel among HIV-1 sero-discordant couples in a phase III clinical trial (MDP 301) in rural south-west Uganda
BACKGROUND A safe and effective vaginal microbicide could substantially reduce HIV acquisition for women. Consistent gel use is… (More)
  • table 1
  • figure 1
  • table 2
  • figure 2
  • table 3
Is this relevant?
Highly Cited
2010
Highly Cited
2010
PRO2000 vaginal gel for prevention of HIV-1 infection (Microbicides Development Programme 301): a phase 3, randomised, double-blind, parallel-group trial
BACKGROUND Innovative prevention strategies for HIV-1 transmission are urgently needed. PRO2000 vaginal gel was efficacious… (More)
  • figure 1
  • table 1
  • table 2
  • table 3
  • table 4
Is this relevant?
2010
2010
Advances in the Development of Microbicides for the Prevention of HIV Infection.
Microbicides are products that can be applied to vaginal or rectal mucosa with the intent of preventing, or at least… (More)
Is this relevant?
Highly Cited
2009
Highly Cited
2009
Disruption of tight junctions by cellulose sulfate facilitates HIV infection: model of microbicide safety.
BACKGROUND The lack of biomarkers that are predictive of safety is a critical gap in the development of microbicides. The present… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
2009
2009
Human glutaredoxin-1 catalyzes the reduction of HIV-1 gp120 and CD4 disulfides and its inhibition reduces HIV-1 replication.
Reduction of intramolecular disulfides in the HIV-1 envelope protein gp120 occurs after its binding to the CD4 receptor. Protein… (More)
Is this relevant?
2008
2008
PRO-2000, an antimicrobial gel for the potential prevention of HIV infection.
Indevus Pharmaceuticals Inc, under license from Paligent Inc, is developing PRO-2000, an antimicrobial gel for the prevention of… (More)
Is this relevant?
2007
2007
Acceptability of PRO2000 vaginal gel among HIV un-infected women in Pune, India.
Acceptability of PRO2000 Gel, a candidate vaginal microbicide, among participants of its Phase I safety study in Pune, India is… (More)
Is this relevant?
2007
2007
Carbohydrate-binding agents efficiently prevent dendritic cell-specific intercellular adhesion molecule-3-grabbing nonintegrin (DC-SIGN)-directed HIV-1 transmission to T lymphocytes.
Exposure of HIV-1 to dendritic cell-specific intercellular adhesion molecule-3-grabbing nonintegrin (DC-SIGN)-expressing B… (More)
Is this relevant?
2001
2001
'Chemical condoms' for the prevention of HIV infection: evaluation of novel agents against SHIV(89.6PD) in vitro and in vivo.
BACKGROUND Vaginal agents which are antiviral and/or inhibit the entry of HIV into the cell could prevent heterosexual… (More)
Is this relevant?